Health
ASLM Partners Africa CDC on Diagnostic Agenda in Africa
The African Society for Laboratory Medicine (ASLM) has partnered with the Africa Centres for Disease Control and Prevention to address existing barriers towards advancing the diagnostic agenda in Africa through the launching of the Africa Collaborative Initiative to Advance Diagnostics (AFCAD).
This strategic partnership was announced during a press conference held on Wednesday, December 12, 2018, at the Transcorp Hilton Hotel, Abuja, to increase access to quality diagnostics towards the achievement of universal health coverage in Africa.
Speaking at the conference, Dr. Yenew Kebede, the Head of Laboratory Division, Africa CDC, stated that Universal Health Coverage is a priority for African countries to attain inclusive and sustainable growth, noting that many diseases remain undiagnosed due to poor diagnostic capacity in most African countries.
He said: “The limited access to essential tests and slow introduction of innovative technologies result in insufficient disease case finding and hampers access to, and monitoring of, treatment. Barriers to diagnostics prevent the African continent from becoming free of epidemic-prone diseases and compromise the achievement of the health agenda of the African Union”.
Other partners on this initiative include: Institut de Recherche, de Surveillance Epidémiologique et de Formation (IRESSEF), World Health Organization Africa Regional Office (WHO-AFRO), Clinton Health Access Initiative (CHAI), African Field Epidemiology Network (AFENET) and UNITAID.
Mr Nqobile Ndlovu, the acting CEO, ASLM said: “This partnership is timely for this period, especially with this year’s conference and its relation to the theme: ‘Controlling the next pandemic: The role of The Laboratory’. ASLM is happy to partner with Africa CDC to launch this initiative in promotion of the diagnostic agenda in the African region through better coordinated and synergized efforts that align with the priorities of Ministries of Health”.
Over the last decade, significant investments have been made by national governments, NGOs, partners and donors to address the technical, health system and financial roots of diagnostic gaps in Africa.
However, there is still a lot more to be done, explained Prof. Alash’le Abimiku, Chairperson, ASLM Board of Directors. “This is why this collaborative effort is so important. When we had the Ebola crisis in Africa, one major challenge laboratory experts had was the time spent in getting the samples tested. Sometimes, it took up to four weeks just for blood samples to get tested because they had to be taken to Germany. But with this new initiative, regulations will be accelerated to facilitate timely and wider access to essential diagnostics”, she said.
The role of AFCAD will be to support efforts that will enable all Member States to achieve equitable access of up to 80 percent coverage to the essential package of healthcare, taking advantage of technological innovations delivered through optimized integrated laboratory networks. This is expected to support achievement of the Sustainable Development Goals as well as improved adherence to International Health Regulations (2015).
AFCAD will also support African health systems through early detection and prevention of antimicrobial resistance, reducing the barriers to early detection, prevention and management of non-communicable diseases such as cardiovascular diseases, diabetes and cancers, as well as preventing disease outbreaks and reducing their human, economic and social cost by instituting early warning systems and ensuring timely detection and diagnosis of epidemic-prone diseases.
AFCAD aims to address diagnostic gaps holistically. The initiative will share information and compare various investments made across the disease areas. The identification of complementarities, overlaps and gaps will provide clarity about whether end-to-end solutions exist and are being implemented.
Health
Court Okays FCCPC to Regulate Consumer Protection in Healthcare
By Adedapo Adesanya
The Abuja division of the Federal High Court has delivered a landmark ruling reinforcing consumer protection in Nigeria’s healthcare sector, affirming the authority of the Federal Competition and Consumer Protection Commission (FCCPC) to investigate complaints related to medical services, including alleged negligence.
Justice Emeka Nwite, who presided over the matter, delivered the judgment on April 15 in a suit filed by Life Bridge Medical Diagnostic Centre Ltd.
The company had challenged the FCCPC’s jurisdiction, arguing that the commission could not probe medical negligence cases without first establishing a formal arrangement with the Medical and Dental Council of Nigeria (MDCN).
However, the court dismissed the claims, holding that healthcare providers operating as commercial entities fall squarely under the provisions of the Federal Competition and Consumer Protection Act (FCCPA).
Justice Nwite ruled that services rendered for value, including medical diagnostics, are subject to consumer protection oversight.
In the decisive clarification, the court drew a line between professional regulation and consumer protection. It said that while disciplinary control of medical practitioners remains the responsibility of professional bodies such as the MDCN, the FCCPC retains authority over issues of service quality, fairness, and consumer satisfaction.
The court further held that Section 105 of the FCCPA, which encourages regulatory coordination, does not limit or delay the FCCPC’s statutory powers.
According to the ruling, the absence of a formal agreement with sector regulators does not invalidate the Commission’s authority to act.
Justice Nwite also addressed concerns around patient confidentiality, ruling that ethical obligations do not override lawful investigations carried out in the public interest and in compliance with due process.
Reacting to the judgment, FCCPC executive vice chairman, Tunji Bello, described the decision as a major step toward strengthening consumer rights across all service sectors.
He emphasised that the ruling underscores the principle that consumer protection and professional regulation can coexist without conflict.
Health
Resident Doctors Suspend Proposed Indefinite Strike
By Adedapo Adesanya
The Nigerian Association of Resident Doctors (NARD) has suspended its planned indefinite strike following the federal government’s reversal of the implementation of the reviewed Professional Allowance Table (PAT) and renewed assurances on outstanding payments.
The decision was announced in a communiqué issued at the end of an emergency National Executive Council (NEC) meeting held virtually on Saturday.
NARD had earlier resolved to embark on a total and indefinite strike over the government’s suspension of the reviewed allowance structure and other unresolved welfare concerns affecting resident doctors nationwide.
However, the association said it reconsidered its position after reviewing the outcomes of high-level engagements with key government officials and health-sector stakeholders.
According to the communiqué signed by NARD President, Dr Mohammad Usman Suleiman; Secretary-General, Dr Shuaibu Ibrahim; and Publicity and Social Secretary, Dr Abdulmajid Yahya Ibrahim, the Federal Government has now reversed its earlier decision on the allowance table.
“The NEC observed that the earlier decision to halt the implementation of the reviewed Professional Allowance Table (PAT) has been reversed, with implementation expected to reflect in the April salary and beyond,” the statement read.
The association also noted the government’s renewed commitment to settling outstanding promotion and salary arrears owed to resident doctors in affected institutions.
In addition, NARD said initial approval had been secured for the 2026 Medical Residency Training Fund (MRTF), with assurances that the disbursement process would be concluded.
“The NEC observed that the Budget Office has indicated its readiness to commence the process for the payment of the outstanding nineteen months’ arrears of the Professional Allowance,” the communiqué added.
Despite the progress, the doctors expressed concern about the continued delay in paying house officers’ salaries and called for urgent action to address the issue.
Following its deliberations, the NEC demanded the sustained implementation of the reviewed allowance structure, the prompt payment of all outstanding arrears, and the expedited disbursement of the residency training fund.
It also called for the immediate commencement of the process to clear the 19-month arrears and the convening of an urgent stakeholders’ meeting to resolve delays affecting house officers’ salaries.
“In light of the above developments, the NEC resolves to suspend the proposed total, indefinite, and comprehensive strike action, with a review of progress to be undertaken at the May Ordinary General Meeting (OGM) in Kano,” the statement said.
NARD expressed appreciation to President Bola Tinubu, Vice President Kashim Shettima, and several ministers, government agencies, and stakeholders for their interventions in resolving the dispute.
Health
Over 1.5 million Nigerian Children Living With Sickle Cell Disease—Report
By Modupe Gbadeyanka
More than 1.5 million children under the age of 15 are living with sickle cell disease in Nigeria, a new international study published in The Lancet Child & Adolescent Health, one of the world’s leading medical journals, has revealed.
In the report made available to Business Post, it was disclosed that Nigeria carries the highest burden of disease globally, far exceeding other high-burden countries such as the Democratic Republic of the Congo and Ethiopia.
The findings highlight both the scale of the challenge in Nigeria and the opportunity for the country to lead Africa in tackling one of the most preventable causes of childhood illness and death.
The study shows that nearly nine million children across sub-Saharan Africa are living with sickle cell disease in 2023, including around 1.17 million infants and 2.75 million children under five, who face the highest risk of early death without treatment.
Sickle cell disease is an inherited blood disorder present at birth. With early diagnosis and access to simple, low-cost interventions such as newborn screening, penicillin prophylaxis, routine vaccinations, malaria prevention, and hydroxyurea, most complications and deaths can be prevented.
However, in Nigeria, access to these essential services remains limited. Many children are only diagnosed after severe and avoidable complications, while others are never diagnosed at all, contributing to high levels of preventable illness and early childhood deaths.
The researchers emphasise that strengthening Nigeria’s health system response will be critical. This includes expanding newborn screening programmes, improving access to essential medicines, and integrating sickle cell care into primary healthcare services.
They called for urgent and coordinated action across government, health institutions, and development partners, including expanding newborn screening programmes, improving access to essential medicines and vaccines, and embedding sickle cell care within primary healthcare services.
The researchers, led by Professor Davies Adeloye, Professor of Public Health at Teesside University, United Kingdom, and Director of the International Society of Global Health (ISoGH), also called for increased domestic investment, supported by international partnerships, as well as stronger data systems to improve surveillance and guide policy decisions.
They concluded that even modest improvements in early-life screening and treatment in high-burden countries like Nigeria could transform child survival and significantly reduce preventable deaths.
“Nigeria now stands at the centre of the global sickle cell crisis. With over 1.5 million children affected, the scale is enormous, but so is the opportunity to act. We already know what works. Newborn screening and early treatment are effective, affordable, and can be delivered through existing health systems.
“If Nigeria prioritises sickle cell disease within its national health agenda and integrates care into routine maternal and child health services, we could save hundreds of thousands of young lives and significantly reduce avoidable deaths.” Professor Adeloye noted.
It was learned that the study analysed data from 40 studies across 22 African countries to produce the most comprehensive country-level estimates of childhood sickle cell disease to date.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn

Pingback: Africa CDC and Unitaid partner to strengthen equitable access to health products in Africa - Top Stories Around The Globe